NEU1 and Hyperglycemia: Given that CathAS190-Neo mice (galactosialidosis model), which have approximately 90% reduction in tissue NEU1 activity, develop type 2 diabetes (48, 49), we sought to document if hyperglycemia was also observed in Neu1-null mice.